- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06459986
The Duration of Spinal Anaesthesia - a Prospective, Observational Cohort Study (Spinalrocks)
The Duration of Spinal Anaesthesia - a Prospective Observational Cohort Study
Study Overview
Status
Conditions
Detailed Description
With the increasing health care cost and the scarcity of nursing staff, there is considerable focus on providing surgery in an ambulatory setting. Total hip and knee arthroplasty (THA and TKA) are now procedures where selected patients are sent home on the same day after the procedure. Therefore, knowledge of key factors affecting the length of stay is important. One factor is the method of anaesthesia used for the operative procedure.
Spinal anaesthesia is often used for THA and TKA and has several advantages compared to general anaesthesia. However, spinal anaesthesia also has drawbacks, because it reduces the force in the legs, hindering early mobilisation. There are no good data on the duration of spinal anaesthesia. Compared to the past, there has been a shift towards using lower doses of local anaesthetic (LA) injected into the subarachnoid space. Theoretically, this should result in a shorter duration of anaesthesia, and this would be of value in an ambulatory setting. However, if the variation in the duration is high and therefore not predictable for the individual patient, spinal anaesthesia has limitations in the ambulatory setting.
The objective of the present study is to prospectively collect data on the type and dose of LA injected into the subarachnoid space and the duration of spinal anaesthesia in participants scheduled for orthopaedic surgery in spinal anaesthesia. We hypothesise that the mean duration of spinal anaesthesia is positively correlated to the dose of LA injected into the subarachnoid space.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kai HW Lange, MD
- Phone Number: +4531909730
- Email: Kai.henrik.wiborg.lange@regionh.dk
Study Locations
-
-
-
Hillerød, Denmark, 3400
- Recruiting
- Anæstesiologisk Afd
-
Contact:
- Kai Lange, MD
- Email: kai.henrik.wiborg.lange@regionh.dk
-
Ringsted, Denmark, 4100
- Recruiting
- Aleris-Ringsted
-
Contact:
- Morten Lind, MD
- Email: morten.lind@aleris.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Scheduled for elective orthopaedic surgical procedures performed in spinal anaesthesia
- ASA 1-4.
Exclusion Criteria:
- Age < 18 years
- Anticoagulant medication therapy not paused according ESAIC/ESRA 2022 guidelines
- Local infection at the lumbar puncture site
- Bleeding disorder
- Unable to cooperate with the spinal anaesthesia procedure.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Spinal anaesthesia
Participants scheduled for orthopaedic surgery performed in spinal anaesthesia with or without sedation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of spinal anasthesia 1
Time Frame: 12 hours
|
Time from subarachnoid LA administration to Bromage score < 3
|
12 hours
|
|
Duration of spinal anaesthesia 2
Time Frame: 12 hours
|
Time from subarachnoid LA administration to Bromage score = 1
|
12 hours
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kai HW Lange, MD, Dept. of Anaesthesiology, Nordsjællands Hospital Hillerød, Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- p-2024-15423
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthopedic Disorder
-
Istituto Ortopedico RizzoliCompleted
-
Hadassah Medical OrganizationUnknownOrthopedic DisordersIsrael
-
Boston Medical CenterRecruiting
-
Kangbuk Samsung HospitalCompletedOrthopedic DisordersKorea, Republic of
-
St. Luke's-Roosevelt Hospital CenterCompletedOrthopedic DisordersUnited States
-
University Hospital of North NorwayHelse NordCompleted
-
Lawson Health Research InstituteUnknownOrthopedic Disorder of Spine
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
Cristália Produtos Químicos Farmacêuticos Ltda.Newco Trials Pesquisa Científica LtdaWithdrawnOrthopedic Disorder of SpineBrazil
-
McGill University Health Centre/Research Institute...CompletedTrauma | Orthopedic DisordersCanada